의약품 광고심의 기준 및 절차 개선을 위한 전문가 의견 조사

Expert Opinion Survey to Improve Criteria and Procedures of Drug Advertisement Review

BACKGROUNDS Since the number of drug advertisements is increasing due to the expansion of advertising markets and the emergence of a new type of advertisement, it is important to review drug advertisements accurately and efficiently. OBJECTIVE We aim to gather and analyze the expert’s opinions regarding the criteria and procedures of drug advertisement review. METHODS Survey questionnaire was sent to 42 members of the drug advertisement review committee. The questionnaire included the key principle of drug advertisement review, the importance of prohibition by type of advertisement, the necessity of permitting by type of advertisement, and questions about current procedures of drug advertisement review. RESULTS In total, 23 of 42 members participated (54.7% response rate). Survey results showed that the ‘Proper expression of efficacy and effectiveness’ and ‘Fair competition among drugs’ were important principles. Prohibition of ‘False advertisements’ and ‘Advertisements that distort facts’ were considered important. The degree of agreement in the need for permission was relatively low, but it was considered relatively necessary to allow ‘Advertisements that present drugs which have been recognized for safe use, such as vitamins.’ All respondents agreed that the number of drug advertisement reviews was high. Approximately 70% of respondents answered that current review fees are not adequate. CONCLUSION This study shows the degree of consensus of experts and provides evidence for further amendment on criteria and procedures of drug advertisement review.